Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

51.71
BATS BZX Real-Time Price
As of 2:05pm ET
 -0.44 / -0.84%
Today’s Change
37.35
Today|||52-Week Range
55.38
+33.62%
Year-to-Date

Today’s Trading

Previous close52.15
Today’s open51.84
Day’s range50.88 - 52.20
Volume55,230
Average volume (3 months)1,287,033
Market cap$4.6B
Dividend yield--
Data as of 2:05pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-48.47%
Earnings growth (next 5 years)-13.59%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book14.39

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp+0.19+0.50%
TECHBio-Techne Corp+1.03+0.87%
BLUEbluebird bio Inc-0.10-0.11%
BIVVBioverativ Inc-0.55-1.00%
Data as of 2:02pm ET, 08/21/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
President, Chief Operating &
Financial Officer
David-Alexandre C. Gros
Corporate headquarters
San Diego, California

Forecasts